- CureToday.com
- OncLive.com
- TargetedOnc.com
- CancerNetwork.com
- Contact
- Terms and Conditions
- Privacy
- Do Not Sell My Personal Information
© 2021 MJH Life Sciences™ and Cancer Network. All rights reserved.
Sara A. Hurvitz, MD | Authors
Articles
Cardiotoxicity of Targeted Agents in Oncology: A Medical Oncology Perspective
June 15, 2014
Without question, targeted therapies have revolutionized the treatment of cancer across histologies.
Novel Agents in Early Trials for Breast Cancer
July 11, 2012
CancerNetwork speaks with Dr. Sara Hurvitz, director of the breast cancer program at the University of California in Los Angeles. Dr. Hurvitz is actively involved in translational phase I/II breast cancer clinical trials as well as in research to better define distinct types of breast tumors to better design novel targeted therapies.